November 15, 2026StocksTechnology·Bullish·biotech
Veraxa Biotech establishes in vitro proof-of-concept for BiTAC-ADC platform and launches partnering discussions at Bio International Convention 2026
Veraxa Biotech announced the successful establishment of in vitro proof-of-concept for its proprietary BiTAC-ADC technology platform. Concurrently, the company launched formal partnering discussions at the Bio International Convention 2026 to explore potential collaborations.
Detected & updated continuously · Source: Nebula
Story subjects